On March 20, Northwell’s research arm — the Feinstein Institutes for Medical Research — began enrolling COVID-19 patients in clinical trials via a collaboration with biopharmaceutical companies Gilead Sciences, Regeneron and Sanofi. The three trials are offered to patients already admitted to our hospitals with moderate to severe COVID-19. The trials are not currently available to the general public.
Northwell Health website, March 2020
Gia Miller is an award-winning journalist and content writer who lives in Katonah. Her work has appeared in Parents, The Washington Post, Healthline, Well + Good, Psych Central, SheKnows, SELF and more.